中文簡(jiǎn)介

由Future Drugs出版。國(guó)際標(biāo)準(zhǔn)書(shū)號(hào)：1473-7140。對(duì)抗癌治療的專(zhuān)家審查提供了專(zhuān)家評(píng)估和評(píng)論癌癥護(hù)理的主要趨勢(shì)，并強(qiáng)調(diào)了新的治療和診斷方法的性能。覆蓋范圍包括腫瘤管理、新藥、抗癌劑和化療、生物療法、癌癥疫苗、治療適應(yīng)癥、生物標(biāo)志物和診斷以及治療指南。所有的文章都要經(jīng)過(guò)嚴(yán)格的同行評(píng)審，雜志對(duì)癌癥治療的決策做出了重要的貢獻(xiàn)。

投稿網(wǎng)址：https://mc.manuscriptcentral.com/ert

英文簡(jiǎn)介

Published by Future-Drugs. ISSN: 1473-7140.Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.